BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 23, 2015
View Archived Issues
Prevention of HIV transcription from latency by Tat inhibitor
Read More
BioRestorative Therapies to evaluate encapsulation technology for use in metabolic program
Read More
Dauntless Pharmaceuticals closes series A financing, licenses technology from Aegis
Read More
KalVista Pharmaceuticals raises funds to advance plasma kallikrein inhibitor pipeline
Read More
Merck & Co.'s Keytruda approved in Europe for advanced melanoma
Read More
Novartis presents milestones of second quarter 2015
Read More
Discovery and optimization of a pan-RET/VEGFR-2 dual inhibitor for single-agent polypharmacology
Read More
New organotypic brain slice culture model helps elucidate Alzheimer's disease pathology
Read More
Horizon Pharma increases share offer for Depomed
Read More
CNGA2 KO mice show AD-like pathological features
Read More
Beaufour Ipsen Tianjin Pharmaceutical describes AR degraders
Read More
Intra-Cellular Therapies plans phase III program for ITI-007 in bipolar depression
Read More
Polyphor reports selective elastase inhibitors
Read More
Catalyst initiates rolling NDA for Firdapse in LEMS
Read More
West China Hospital, Sichuan University reports short-acting anesthesic
Read More
Novartis files sBLA for ofatumumab as maintenance therapy for relapsed CLL
Read More
Alectos Therapeutics designs GCase inhibitors
Read More
Erum Biotechnologies patents PTP-1B inhibitors
Read More
Vidasym's phosphate binder VS-505 enters phase I/II trial
Read More
Phase I study investigates T4 immunotherapy for head and neck cancer
Read More
Xoma reports data from phase III EYEGUARD-B study
Read More
Roche Diagnostics launches HTLV blood test
Read More
AMAG Pharmaceuticals obtains option to acquire digoxin immune fab for pre-eclampsia
Read More
NIH funds collaborative project to develop measures of social impairment in autism
Read More